The catalytic subunit of DNA-PK regulates transcription and splicing of AR in advanced prostate cancer
Aberrant androgen receptor (AR) signaling drives prostate cancer (PC), and it is a key therapeutic target. Although initially effective, the generation of alternatively spliced AR variants (AR-Vs) compromises efficacy of treatments. In contrast to full-length AR (AR-FL), AR-Vs constitutively activat...
Principais autores: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Artigo |
Idioma: | English |
Publicado em: |
American Society for Clinical Investigation
2023-11-01
|
coleção: | The Journal of Clinical Investigation |
Assuntos: | |
Acesso em linha: | https://doi.org/10.1172/JCI169200 |